On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
As global life sciences companies seek locations that combine skilled talent, scalable infrastructure, a...
In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...
When Najat Khan steps into her new role as CEO and President of Recursion, she inherits more than a celebrated...
In a special conversation with BioSpectrum Asia, Yang Huang, Head of China Healthcare Research at J.P. Morgan, shares sh...
With a healthcare market as vast as its population, China is rapidly evolving into a powerhouse for biopharma and medtec...
Sharing his perspectives with BioSpectrum Asia, Narayana Rao Rapolu, Senior Vice President, Global Bioprocessing...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
As Hong Kong accelerates its transformation into a global biotech and MedTech powerhouse, BioSpectrum ...
Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
Could you please share some details of the company's investment plans, and new product development in the coming years?&...
What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...
Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVÅŒQ Nano, reveals the transformative potent...
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cr...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is the Directo...
